Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st March 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | - | - |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | - | - |
The Carillon Eagle Mid Cap Growth Fund delivered mixed results in Q1 2026 as mid-cap growth significantly underperformed value amid sector rotation. The fund's core thesis centers on companies positioned to benefit from AI infrastructure buildout, with top performers Vertiv and Quanta Services capitalizing on accelerating data center investment and hyperscaler capital spending plans. Energy sector exposure proved beneficial as geopolitical tensions from military strikes on Iran drove oil prices above $100 per barrel, though this created broader market uncertainty. The portfolio maintains selective exposure across healthcare, defense, and industrial sectors, with managers favoring companies with strong competitive positions and secular growth drivers. Key risks include continued geopolitical volatility, higher energy prices acting as an economic tax, and AI displacement concerns affecting software companies. Despite near-term turbulence, the managers remain constructive on cyclical areas benefiting from the AI infrastructure cycle and expect current market volatility to be short-lived as valuations have reached more reasonable levels.
The fund focuses on mid-cap growth companies positioned to benefit from secular trends including AI infrastructure buildout, energy sector recovery, and cyclical improvement in manufacturing, while maintaining selective exposure across healthcare, defense, and consumer sectors during a period of heightened geopolitical uncertainty.
The managers are optimistic that current market turbulence will be short-lived, expecting the Middle East war to be relatively brief given the administration's focus on gasoline prices and upcoming midterm elections. They remain broadly constructive on cyclical areas of the market, particularly those benefiting from AI infrastructure spending. The tone is cautiously optimistic despite acknowledging heightened uncertainty from geopolitical risks and energy price volatility.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Apr 15 2026 | 2026 Q1 | ARES, AXON, CASY, CVNA, PWR, RBLX, RDDT, TER, VRT, XPO | AI, defense, energy, Geopolitical, growth, healthcare, mid cap, technology |
VRT TER CASY PWR XPO ARES CVNA AXON RBLX RDDT |
Mid-cap growth fund focused on AI infrastructure beneficiaries like Vertiv and Quanta Services, which drove outperformance despite broader sector weakness. Energy exposure provided upside from Iran tensions pushing oil above $100. Managers remain constructive on cyclical areas benefiting from AI spending despite geopolitical uncertainty, expecting current volatility to be temporary as valuations normalize. |
| Jan 19 2026 | 2025 Q4 | ALNY, ARES, AXON, COR, CRS, CVNA, HLT, LPLA, MDB, NTRA, RBA, RBLX, RCL, ROST, TER, VEEV, VRT, VST | aerospace, AI, Biotech, consumer, growth, healthcare, mid cap, technology |
NTRA TER CRS ROST MDB RBLX AXON RCL VST VEEV |
Mid-cap growth fund positioned for 2026 outperformance through AI cycle continuation, fiscal stimulus, and sector rotation opportunities. Strong exposure to semiconductor testing, aerospace recovery, and healthcare demographics with quality companies generating robust free cash flows. Key risks include labor market softening and AI investment sustainability, but multiple cyclical inflection points support optimistic outlook. |
| Oct 19 2025 | 2025 Q3 | ALNY, ARES, AXON, COR, CVNA, DXCM, FICO, HLT, INSM, MDB, MPWR, NET, RBA, RBLX, RCL, TTD, VRT, WING, WYNN | AI, defense, growth, healthcare, mid cap, Natural Gas, technology, Travel |
MPWR US WYNN US ALNY US INSM US MDB US |
Mid-cap growth fund positioned for AI adoption beyond infrastructure, healthcare sector recovery, natural gas demand growth, and defense spending expansion. Team actively seeks quality companies at reasonable valuations while avoiding speculative AI infrastructure stocks. Consumer exposure focuses on experiential spending trends. Balanced outlook reflects strong growth expectations tempered by market frothiness concerns. |
| Jul 27 2025 | 2025 Q2 | ALNY, ARES, AXON, COR, CVNA, DXCM, FICO, HLT, INSM, MDB, MPWR, NET, RBA, RBLX, RCL, TTD, VRT, WING, WYNN | AI, Biotechnology, defense, energy, growth, healthcare, mid cap, technology |
PLTR AXON RCL NET VST BKR SRPT OKTA RYAN RH WYNN ALNY INSM MDB MPWR TTD AXON WING FICO DXCM |
Mid-cap growth fund positioned across AI adoption, healthcare recovery, energy transition, and defense themes. Shifting from expensive AI infrastructure to reasonably valued adopter companies. Healthcare offers compelling valuations post-COVID underperformance with M&A pickup. Natural gas and aerospace fundamentals remain strong. Cautious on market speculation but constructive on quality growth companies with Fed support. |
| Mar 31 2025 | 2025 Q1 | APP, ARES, AXON, BKR, CELH, COR, DDOG, DECK, ITCI, LPLA, MRVL, PLTR, RBA, TTD, WAB, WCN | AI, energy, growth, healthcare, mid cap, technology, Trade Policy | - | Mid-cap growth fund weathered Q1 volatility through defensive positioning in healthcare distributors and waste management while technology holdings faced AI spending and tariff headwinds. Managers remain constructive on valuations, expecting policy clarity to drive recovery. Portfolio emphasizes durable growth companies across healthcare, technology, and consumer sectors with secular tailwinds despite near-term macro uncertainty. |
| Jan 17 2025 | 2024 Q4 | APP, ARES, AXON, BAH, BKR, COR, ENTG, FND, GWW, LPLA, MPWR, MRVL, RBA, RCL, TTD, WAB, WING | AI, consumer, financials, growth, healthcare, mid cap, semiconductors, technology |
APP AXON MRVL |
Mid-cap growth fund positioned for 2025 broadening beyond AI mega-caps, benefiting from Fed easing and pro-business policies. Strong exposure to AI infrastructure, aerospace recovery, and travel demand while managing risks from elevated sentiment, policy uncertainty, and potential AI spending overcapacity. Cautiously optimistic with selective positioning across technology, industrials, and consumer discretionary sectors. |
| Sep 30 2024 | 2024 Q3 | ARES, AXON, BKR, CELH, COR, CRWD, DXCM, ENTG, FICO, GEV, GWW, RBA, RCL, ROST, SNPS, TTD, VST, WAB, WCN | AI, energy, growth, healthcare, industrials, mid cap, semiconductors, technology |
GEV AXON VST FICO WAB DXCM CELH CRWD SNPS ENTG |
Mid-cap growth fund targeting secular growth companies with strong balance sheets positioned for AI infrastructure trends. Top performers GE Vernova and Axon Enterprise drove returns while Dexcom and Celsius detracted. Managers maintain AI exposure while managing position sizes, favor aerospace aftermarket growth, and see healthcare rotation opportunity ahead. Fed dovishness supports cautiously optimistic outlook despite ongoing uncertainty. |
| Jul 26 2024 | 2024 Q2 | ALNY, BKR, CELH, COR, CRWD, DASH, DXCM, ENTG, FIVE, GEV, MPWR, RBA, ROST, SNPS, TYL, ULTA, WAB, WCN | AI, energy, growth, healthcare, industrials, mid cap, technology | - | Mid-cap growth fund targeting companies with strong balance sheets and exposure to AI data centers, cybersecurity, healthcare innovation, and energy transition. Managers remain constructive on markets despite Fed hawkishness concerns. Portfolio emphasizes secular growth themes while maintaining defensive positioning through companies generating significant free cash flows and durable business models. |
| Apr 15 2024 | 2024 Q1 | BKR, CELH, CRWD, DXCM, ENTG, LULU, MKTX, MLM, PLNT, RBA, ROST, SBAC, SNPS, SWAV, U, VRT, WCN | AI, Data centers, growth, healthcare, industrials, infrastructure, mid cap, technology | - | Mid-cap growth fund benefited from AI infrastructure themes and cybersecurity demand in Q1. Key winners included Celsius, CrowdStrike, and Vertiv, while the team trimmed underperformers. Managers maintain constructive outlook on secular growth themes but actively manage momentum exposure. Focus remains on companies positioned for data center expansion, healthcare innovation, and infrastructure spending acceleration. |
| Jan 27 2024 | 2023 Q4 | BILL, CRWD, DXCM, GTLS, HAL, MPWR, PAYC, PLNT, SNPS, TRU | AI, cybersecurity, energy, growth, healthcare, mid cap, semiconductors, technology | - | Mid-cap growth fund focused on companies generating strong free cash flow through cycles, with emphasis on AI, cybersecurity, and healthcare themes. Top holdings include CrowdStrike and Dexcom, both benefiting from secular tailwinds. Managers remain optimistic for 2024 following Fed dovish pivot but maintain disciplined risk management approach given potential monetary policy lag effects. |
| Sep 30 2023 | 2023 Q3 | ALB, BKR, CELH, CMG, CRWD, DXCM, HAL, PEN, PLNT, SNPS | AI, cybersecurity, energy, growth, healthcare, interest rates, mid cap, technology | - | Mid-cap growth fund delivered mixed Q3 results with energy and cybersecurity winners offset by healthcare concerns over GLP-1 drugs. Managers remain constructive on growth stocks with secular drivers despite rising real rates creating economic uncertainty. Focus on AI beneficiaries, energy transition plays, and quality companies with strong balance sheets positioned for long-term outperformance. |
| Jul 27 2023 | 2023 Q2 | ALNY, ARES, AXON, COR, CVNA, DXCM, FICO, HLT, INSM, MDB, MPWR, NET, RBA, RBLX, RCL, TTD, VRT, WING, WYNN | AI, Biotechnology, defense, energy, growth, healthcare, mid cap, technology |
MPWR ASIC|CWAN|INSP|KRMN|KTOS|MAC|MEG|RH|WYNN ALNY INSM MDB ARIS|BAB LN|GDDY|GXI|III LN|IOT|IRTC|MIPS SS|RBC|SAIA|SPOT|SRT GR|TTD|WING AXON ARIS|BAB LN|GDDY|GXI|III LN|IOT|IRTC|MIPS SS|RBC|SAIA|SPOT|SRT GR|TTD|WING FICO DXCM |
Mid-cap growth managers see continued AI adoption opportunities while avoiding overvalued infrastructure plays. Healthcare sector recovery underway with M&A pickup and attractive valuations. Defense spending and natural gas demand provide durable growth themes. Market froth in speculative areas creates vulnerability but potential flight-to-quality opportunity for solid growth companies. |
| Mar 31 2023 | 2023 Q1 | ALNY, ARES, AXON, COR, CVNA, DXCM, FICO, HLT, INSM, MDB, MPWR, NET, RBA, RBLX, RCL, TTD, VRT, WING, WYNN | AI, Data centers, defense, growth, healthcare, mid cap, Natural Gas, technology |
MPWR ASIC|CWAN|INSP|KRMN|KTOS|MAC|MEG|RH|WYNN ALNY INSM MDB ARIS|BAB LN|GDDY|GXI|III LN|IOT|IRTC|MIPS SS|RBC|SAIA|SPOT|SRT GR|TTD|WING |
Mid-cap growth fund maintains diversified exposure to AI adoption, healthcare innovation, natural gas demand, and defense spending. Strong Q3 contributors included semiconductor power management and Macau gaming recovery. Team seeks AI adopters at reasonable valuations while cautious on infrastructure multiples. Constructive economic outlook supported by potential Fed cuts and fiscal stimulus. |
| Jan 19 2023 | 2022 Q4 | ALB, BKR, CRWD, GNRC, HAL, HZNP, MRVL, PLNT, URI, WOLF | - | - | |
| Oct 28 2022 | 2022 Q3 | ALB, AVTR, BKR, ENPH, FLT, LPLA, SGEN, TRU, WCN, WOLF | - | - | |
| Jun 30 2022 | 2022 Q2 | - | - | - |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q1 |
AIAI infrastructure spending remains a bright spot with hyperscaler capital expenditure commitments continuing to underpin demand visibility for hardware and advanced semiconductors. Companies like Vertiv and Quanta Services are well positioned to benefit from accelerating data center investment driven by rapid expansion in high-performance computing and artificial intelligence. The software sector continues to grapple with both real and perceived displacement risk from increasing AI capabilities. |
Data Centers Semiconductors Cloud Infrastructure Software Hardware |
EnergyEnergy sector returned exceptionally strong performance during the first quarter following military strikes on Iran that sent energy prices sharply higher. Oil prices rose above $100 per barrel, creating volatility but the sector remains at depressed valuations. The outlook for natural gas continues to improve as cold winter reduced surplus storage levels, while demand from LNG export facilities and power generation for data centers continues to rise sharply. |
Oil Natural Gas LNG Energy Trading Exploration & Production | |
HealthcareHealthcare industry remains the largest sector in the US with total expenditures exceeding $5 trillion and accounting for 18% of GDP, growing at about 5% per year driven by aging population and increasing prevalence of chronic conditions. Despite sector importance, healthcare has underperformed in recent years, working off COVID-19 pandemic excesses. Recent M&A activity has been robust, with much focused on medical device and biotechnology companies, while many healthcare companies are trading at historically attractive valuations. |
Biotechnology Medical Devices Biopharma M&A Healthcare IT Pharmaceuticals | |
DefenseWithin industrials, the fund continues to favor companies with exposure to aerospace and defense as the US Department of War needs to restock depleted munitions and other allied countries begin to build up military capacities in an increasingly uncertain geopolitical landscape. The preference is shifting toward original equipment exposed companies, especially those with greater content on next-generation commercial aircraft platforms. |
Defense Spending Aerospace Defense Components Ammunition Defense Electronics | |
TruckingThe trucking sector has seen an improving environment with freight rates rising in response to improved manufacturing activity and falling supply as trucks driven by undocumented immigrants exit the market. XPO delivered strong performance despite a challenging freight environment, with execution particularly evident in improving service levels and helping to narrow the market share and pricing gap with best-in-class peers. |
Logistics Freight Brokerage Transportation Industrial Services Supply Chain | |
| 2025 Q4 |
ValuationsUS share markets are trading nearly as expensively as they ever have relative to history. The manager presents detailed analysis showing strong negative correlation between high P/E ratios and subsequent 10-year returns, with current forward P/E of 25.6 suggesting poor future returns of -5% to +5% annualized. |
P/E Ratios Market Multiples Forward Earnings Historical Analysis |
AIArtificial Intelligence continued to drive investor excitement and market returns during the period. US company earnings are forecast to grow by 44% over the next three years, driven largely by investors' expectations for AI companies to start delivering on their lofty targets. |
Artificial Intelligence Earnings Growth Technology Market Leadership | |
Trade PolicyEarly studies show that roughly 90% of tariff costs are being borne by US consumers and companies, contrary to Trump administration narrative. Tariffs alone added 0.7% to US inflation in 2025 and made the typical US household $600 poorer, presenting longer-term headwinds to the US economy. |
Tariffs Inflation Consumer Costs Economic Policy | |
EarningsThe US share market delivered earnings per share growth of 12.8% over calendar year 2025, more than twice the earnings growth seen in 2024 and well above long-run average growth figures. This earnings growth has been largely broad-based across many different business sectors. |
EPS Growth Corporate Performance Broad-based Growth | |
| 2025 Q3 |
AIThe AI investment theme will remain intact into the end of the year as user adoption continues to accelerate and corporate implementations begin to bear fruit. The team is actively seeking AI adopter companies that trade at reasonable multiples and are well positioned to see potential inflection in earnings growth fueled by AI-driven margin expansion. Companies with exposure to the buildout of AI data centers have performed remarkably well in 2025 as hyperscalers have revised capital expenditure plans significantly higher. |
Data Centers Hyperscalers Margin Expansion Infrastructure Adoption |
HealthcareHealthcare remains the largest sector in the United States with total expenditures reaching $5 trillion and accounting for 17.7% of GDP. The sector has been working off excesses from the COVID-19 pandemic but shows reasons for optimism with recent M&A activity picking up and biotechnology stocks getting a boost from declining interest rates. The team believes interest in healthcare stocks could see a resurgence once investors are comfortable with policy and regulatory overhangs. |
Biotechnology M&A Regulatory Demographics Innovation | |
Natural GasThe team remains positive on natural gas, expecting multi-year demand growth from both liquefied natural gas export facilities and new power generation required by data centers. On the supply side, they expect the pace of growth for associated gas volumes from oil wells in the Permian Basin to slow in response to weakening oil prices. |
LNG Data Centers Supply Permian Export | |
DefenseThe team continues to see a favorable setup for the aerospace and defense industry. Robust spending growth in new and emerging areas, anchored by the strategic priorities of the U.S. Department of Defense and NATO partners, offers durable visibility and supports a resilient growth profile for the industry moving forward. |
NATO Spending Aerospace Strategic Growth | |
TravelConsumers broadly continue to prioritize travel and experiences over goods. The team remains excited about companies offering uncommon experiences, such as cruise vacations and spa treatments while on cruises, as part of the ongoing consumer preference shift toward experiential spending. |
Experiences Cruises Consumer Discretionary Leisure | |
| 2025 Q2 |
AIThe AI investment theme remains intact with continued user adoption acceleration and corporate implementations bearing fruit. The team is actively seeking AI adopter companies trading at reasonable multiples positioned for earnings growth through AI-driven margin expansion. Current lofty multiples of AI infrastructure stocks imply strong growth trajectories with little margin for error. |
Artificial Intelligence Data Centers Infrastructure Adoption Margin Expansion |
HealthcareHealthcare represents the largest US sector at $5 trillion (17.7% of GDP) growing 5% annually driven by aging population and chronic conditions. The sector has underperformed recently due to COVID-19 deceleration and biotech IPO quality issues. Recent M&A activity pickup and favorable valuations present opportunities, particularly in predictable US-centric businesses like distributors. |
Aging Population Chronic Conditions M&A Biotechnology Medical Devices | |
Energy TransitionCapital spending for manufacturing facilities expected to see strong tailwinds from tax benefits in recent legislation and tariff-driven reshoring initiatives. Natural gas positioned for multi-year demand growth from LNG export facilities and data center power generation requirements. |
Manufacturing Reshoring Natural Gas LNG Data Centers | |
Defense SpendingFavorable setup for aerospace and defense industry with healthy aftermarket fundamentals in commercial jet engines and aging global fleet driving elevated servicing demand. Robust spending growth in new areas anchored by US Department of Defense and NATO strategic priorities offers durable visibility. |
Aerospace Commercial Aviation NATO Defense Electronics Aftermarket | |
TravelConsumers continue to prioritize travel and experiences over goods. Companies offering uncommon experiences such as cruise vacations remain areas of excitement. Gaming operations in Macau showed steady monthly improvement marking the first sustained recovery in the region. |
Experiences Cruises Macau Gaming Consumer Preferences | |
| 2025 Q1 |
AIThe fund remains optimistic on AI investment cycle despite market concerns about slowing hyperscaler spending. They believe the investment cycle to support AI technology is still in early innings and expect continued buildout of data centers and related infrastructure. |
Data Centers Hyperscalers Infrastructure Investment Cycle Technology |
Trade PolicyTariff uncertainty has significantly impacted market sentiment and portfolio positioning. The fund expects clarity around tariffs to act as a positive catalyst as uncertainty is removed, though current policy ambiguity creates headwinds for cyclical areas. |
Tariffs Policy Uncertainty Global Trade Economic Impact Market Volatility | |
Biopharma M&AHealthcare M&A activity has picked up with significant acquisitions in medical device and pharmaceutical industries. Companies are seeking to expand portfolios and enhance market positions, providing opportunities in the sector. |
Healthcare Medical Devices Pharmaceuticals Portfolio Expansion Market Consolidation | |
Energy TransitionDespite oil service activity remaining depressed, natural gas prices have firmed based on improved outlook for power generation demand and LNG export capacity. The fund sees mixed signals in the energy transition landscape. |
Natural Gas LNG Power Generation Oil Services Energy Infrastructure | |
| 2024 Q4 |
AIAI investment theme drove significant market returns in 2024, with one major chip designer's data center revenues expected to represent 15% of total US capital spending in 2025. Hyperscalers need to generate $400 billion in revenue from AI to justify current spending levels, though user surveys suggest GenAI applications are meeting or exceeding expectations across industries. |
Data Centers Semiconductors GenAI Hyperscalers Capital Spending |
Data CentersElectrical equipment companies with data center exposure positioned to benefit from announced hyperscaler capital expenditure plans driving strong growth. AI data centers creating increased electricity generation demand, supporting natural gas demand and benefiting electrical equipment providers. |
Electrical Equipment Hyperscalers AI Infrastructure Power | |
TravelConsumers continue to prioritize travel and experiences, with cruise demand remaining strong and expected to gain market share from land-based vacations. Royal Caribbean saw strong quarterly earnings with positive 2025 outlook driving stock performance during the quarter. |
Cruises Consumer Spending Experiences Tourism Leisure | |
SemiconductorsSemiconductor sector showing mixed signals with AI-related strength offset by concerns about broader cycle slowdown. Companies like Marvell Technology highlighting strong AI orders and design wins, while others face market share competition and cyclical headwinds in non-AI segments. |
AI Data Centers Memory Chip Designers Cyclical | |
| 2024 Q3 |
AIThe dramatic growth in AI infrastructure investment remains a dominant theme in the market, with hundreds of billions being invested by mega-cap tech companies. The fund holds positions well positioned to benefit from this trend, though managers remain vigilant of potential drawdown risks in AI winners. |
Infrastructure Investment Technology Semiconductors Data Centers |
Energy TransitionThe fund holds names in electrical equipment that should see growth acceleration due to surge in AI infrastructure investment leading to significant power consumption growth. GE Vernova is positioned to capitalize on power demand growth across gas turbines and electrical transmission products. |
Power Grid Electrical Equipment Infrastructure Demand | |
HealthcareHealthcare stocks continue working off COVID-induced excesses, with clinical research organizations facing challenges as biotech and pharma companies become more selective in drug development. The sector is likely close to an inflection point where investment dollars rotate back into healthcare. |
CRO Biotech Pharmaceuticals Clinical Trials Recovery | |
TravelConsumers continue to prioritize travel and experiences, with the fund excited about companies offering unique experiences ranging from cruise vacations to amusement parks. The aerospace and defense sector benefits from aftermarket parts growth as aircraft use is extended. |
Experiences Cruises Aerospace Aftermarket Consumer | |
SemiconductorsThe fund maintains exposure to semiconductor-related names despite concerns about the overall semiconductor cycle. Entegris is positioned as a key consumable supplier where products become more critical as chip complexity rises, even in a broader industry slowdown. |
Cycle Equipment Materials Complexity Consumables | |
| 2024 Q2 |
AIThe fund continues to see strong momentum within the AI data center buildout megatrend. The enormous power requirements of AI data centers have positive implications for a broader group of stocks extending across energy, industrials and utilities. The portfolio is well positioned to benefit from this theme as the surge in capital spending plans from mega-cap tech companies holds significant positive implications for several holdings within the electrical equipment and power generation industries. |
Data Centers Power Equipment Electrical Equipment Capital Spending Infrastructure |
CybersecurityThe cyber threat environment remains elevated, and the rise of artificial intelligence will likely make it easier for criminals and threat actors to design and launch sophisticated attacks, increasing the need for cybersecurity solutions. CrowdStrike Holdings, a security software provider, reported strong earnings results with strength in endpoint security, cloud security, vulnerability management, and identity protection. |
Security Software Endpoint Security Cloud Security Threat Protection Identity | |
HealthcareThe healthcare sector continues to lag but reached an important milestone crossing over the $5 trillion level, representing 17.7% of national GDP. The fund sees opportunities in distributors benefiting from explosive growth in GLP-1 anti-obesity drugs, contract research organizations, and companies with disruptive technologies including imaging centers, organ preservation, and potential FDA approval for breast implant improvements. |
GLP1 Medical Devices CRO & CDMO Medical Distribution Imaging | |
Energy TransitionGE Vernova is well positioned to capitalize on growing power demand trends across its various products and services, most notably within large-scale gas turbine equipment and related services, as well as high-voltage electrical transmission products. The increasing outlook for power demand growth both domestically and abroad supports this positioning. |
Power Equipment Gas Turbines Transmission Grid Upgrade Electrical Equipment | |
| 2024 Q1 |
AIThe fund is positioned to benefit from AI-driven data center spending acceleration, with holdings in companies like Vertiv that provide critical infrastructure for high-performance computing. The team monitors AI application adoption to assess sustainability of the investment cycle and its impact on market leadership. |
Data Centers Infrastructure Computing Investment Cycle Applications |
Data CentersData center spending is accelerating due to rapid growth in high-performance computing and artificial intelligence, driving demand for new and retrofitted facilities requiring significantly more power and cooling content. This creates opportunities for companies with leading positions in data center power and thermal management. |
Power Cooling Infrastructure Hyperscalers Semiconductors | |
CybersecurityThe cyber threat environment remains elevated, with artificial intelligence likely making it easier for criminals to design sophisticated attacks. This increases demand for cybersecurity solutions, benefiting companies like CrowdStrike that provide endpoint security, cloud security, and identity protection. |
Threat Environment Endpoint Security Cloud Security Identity Protection AI Threats | |
GLP1The fund has exposure to GLP-1 weight-loss drugs, which have proven very effective in treating Type 2 diabetes and obesity. One investment paid off with impressive trial results that spurred a dramatic rise in the stock price. |
Weight Loss Diabetes Obesity Clinical Trials Drug Development | |
Infrastructure SpendingAccelerating infrastructure spending and improving residential construction trends provide a runway for potential volume growth inflection. The planned build-out of AI data centers is expected to drive significant investments from utilities on renewable power and transmission infrastructure. |
Construction Utilities Renewable Power Transmission Volume Growth | |
OnshoringIndustrial sector benefits from solid growth prospects due to re-shoring initiatives, automation, and infrastructure stimulus. The profit outlook is supported by sticky price increases and margin improvement opportunities from higher labor productivity and improved supply chains. |
Re-shoring Automation Labor Productivity Supply Chains Margin Improvement | |
| 2023 Q4 |
AIArtificial intelligence applications are driving demand for semiconductor chips and enterprise data centers. The rise of AI is expected to make it easier for criminals to generate sophisticated cyber attacks, increasing demand for security software. Technology companies are leveraging AI in new product announcements. |
Artificial Intelligence Enterprise Data Centers Semiconductors Cybersecurity |
CybersecurityCyber threats remain elevated with strong demand for cloud security and identity protection. The rise of artificial intelligence is expected to enable more sophisticated attacks, driving increased demand for cybersecurity products in the years ahead. |
Cloud Security Identity Protection Cyber Threats Security Software | |
GLP1GLP-1 weight-loss medications initially created investor concerns about reduced demand for diabetes monitoring devices and medical procedures. However, internal analysis revealed that patients taking GLP-1s actually used continuous glucose monitors at twice the rate of patients not on GLP-1s. |
Weight Loss Diabetes Medical Devices Healthcare | |
Semiconductor CycleSemiconductor industry fundamentals have been mixed with fluctuating ordering patterns and limited visibility into automotive and industrial end markets. However, high-performance power management chips are benefiting from AI applications and recent design wins suggest improved future orders. |
Semiconductors Automotive Industrial Power Management | |
| 2023 Q3 |
AIThe fund sees generative AI as transformative across various businesses and continues to look for investment opportunities. Synopsys is releasing new tools to help companies use AI to improve semiconductor development projects. The emergence of AI has sparked optimism and increased spending in semiconductors, hardware, and software industries. |
Generative AI Semiconductors Software Hardware Development Tools |
GLP1GLP-1 agonist drugs pose a significant threat to medical device companies as they can reduce obesity, diabetes, and related conditions. This has caused investor concerns about reduced demand for insulin pumps, CGMs, and cardiac procedures. However, the fund believes adoption may be limited due to lifetime usage requirements, high costs, and adverse side effects. |
Weight Loss Medical Devices Diabetes Obesity Healthcare | |
Energy TransitionBaker Hughes is well-positioned to benefit from emerging energy technologies including green hydrogen and carbon capture. The fund sees opportunities in the ongoing build-out of LNG infrastructure and the development of alternative energy solutions as part of the broader energy transition. |
Green Hydrogen Carbon Capture LNG Alternative Energy Energy Technology | |
CybersecurityCrowdStrike delivered positive quarterly results driven by large deal momentum in cloud security, identity protection, and security software management. The company showed improved profitability and ramping reseller partnerships, positioning it well in the cybersecurity market. |
Cloud Security Identity Protection Security Software Cyber Protection | |
| 2023 Q2 |
AIThe AI investment theme remains intact with continued user adoption and corporate implementations bearing fruit. The team is actively seeking AI adopter companies trading at reasonable multiples positioned for earnings growth through AI-driven margin expansion. However, they note current lofty multiples of AI infrastructure stocks imply strong growth trajectories with little margin for error. |
Artificial Intelligence Infrastructure Adoption Margin Expansion Valuations |
Data CentersCompanies with exposure to AI data center buildout have performed remarkably well in 2025 as hyperscalers revised capital expenditure plans significantly higher. While risk of potential overcapacity looms, demand trends for computing power appear to support these plans for the foreseeable future. |
Hyperscalers Capital Expenditure Computing Power Overcapacity | |
BiotechnologyBiotechnology stocks are getting a boost from declining interest rates, which could support a prolonged period of positive returns for the industry. The sector has been working off COVID-19 pandemic excesses, with recent M&A activity picking up though remaining below normal levels. |
Interest Rates M&A Activity COVID Recovery Valuations | |
Natural GasThe team remains positive on natural gas, expecting multi-year demand growth from both LNG export facilities and new power generation required by data centers. On the supply side, they expect slower growth pace for associated gas volumes from Permian Basin oil wells in response to weakening oil prices. |
LNG Power Generation Permian Basin Supply Demand | |
HealthcareHealthcare remains the largest US sector at $5 trillion, growing 5% annually driven by aging population and chronic conditions. Despite sector size and importance, it has underperformed recently due to COVID-19 deceleration and regulatory uncertainty. However, recent M&A activity pickup and favorable valuations provide reasons for optimism. |
Aging Population Chronic Conditions M&A Activity Regulatory Uncertainty | |
DefenseThe team sees a favorable setup for aerospace and defense with healthy aftermarket fundamentals in commercial jet engines and aging global fleet driving elevated servicing demand. Robust defense spending growth in new areas anchored by US Department of Defense and NATO strategic priorities offers durable visibility. |
Aftermarket Commercial Aviation NATO Defense Spending | |
| 2023 Q1 |
AIThe AI investment theme will remain intact into the end of the year as user adoption continues to accelerate and corporate implementations begin to bear fruit. The team is actively seeking AI adopter companies that trade at reasonable multiples and are well positioned to see a potential inflection in earnings growth fueled by AI-driven margin expansion. However, they recognize that current lofty multiples of many AI infrastructure stocks imply a strong growth trajectory for the next several years and leave little margin for error. |
Infrastructure Adoption Margin Expansion Valuations Data Centers |
Data CentersCompanies with exposure to the buildout of AI data centers have performed remarkably well in 2025 as hyperscalers have revised capital expenditure plans significantly higher. While the risk of potential overcapacity looms, demand trends for computing power appear to support these plans for the foreseeable future. |
Hyperscalers Capital Expenditure Computing Power Overcapacity | |
HealthcareHealthcare remains the largest sector in the United States with total expenditures reaching $5 trillion and accounting for 17.7% of GDP. The sector has been working off the excesses brought on by the COVID-19 pandemic but there are reasons for optimism including recent M&A activity pickup and more favorable valuations. Biotechnology stocks are getting a boost from the downtick in interest rates. |
M&A Valuations Biotechnology Interest Rates | |
Natural GasThe team remains positive on natural gas, expecting the commodity should see multi-year demand growth from both liquefied natural gas export facilities and the new power generation required by data centers. On the supply side, they expect the pace of growth for associated gas volumes from oil wells in the Permian Basin to slow in response to weakening oil prices. |
LNG Power Generation Permian Basin Supply | |
DefenseThe team continues to see a favorable setup for the aerospace and defense industry. Robust spending growth in new and emerging areas, anchored by the strategic priorities of the U.S. Department of Defense and its partners in NATO, offers durable visibility and supports a resilient growth profile for the industry moving forward. |
Spending NATO Growth Profile Visibility |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | RDDT | Internet Content & Information | Interactive Media & Services | Neutral | New York Stock Exchange | advertising, LLM Data Licensing, Online Community Platform, Revenue Growth, social media, stock buyback, Unique Audience, User growth | Login | |
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | VRT | Vertiv Holdings | Electrical Equipment & Parts | Technology Hardware, Storage & Peripherals | Bull | New York Stock Exchange | AI infrastructure, critical infrastructure, data centers, high-performance computing, hyperscale, Power management, semiconductors, thermal management | Login |
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | TER | Teradyne | Semiconductor Equipment & Materials | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | AI workloads, ASIC Testing, market share gains, Next-Generation Memory, Semiconductor Testing, semiconductors, Testing Equipment | Login |
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | CASY | Casey's General Stores | Specialty Retail | Food & Staples Retailing | Bull | NASDAQ | convenience stores, Fuel margins, In-Store Sales, Midwest, oil prices, Pizza, Prepared foods, Rural Markets | Login |
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | PWR | Quanta Services | Engineering & Construction | Construction & Engineering | Bull | New York Stock Exchange | AI infrastructure, backlog growth, Connectivity, Construction & Engineering, data centers, Electric Utility, Infrastructure Solutions, Power Infrastructure | Login |
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | XPO | XPO | Trucking | Road & Rail | Bull | New York Stock Exchange | Cyclical Recovery, freight transportation, Less-than-truckload, Ltl, Manufacturing PMI, market share, Service Levels, Transportation Services | Login |
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ARES | Ares Management | Asset Management | Capital Markets | Bull | New York Stock Exchange | Alternative Asset Manager, asset management, diversification, infrastructure, Institutional Products, Private Credit, private equity, Real Estate | Login |
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | CVNA | Carvana | Auto & Truck Dealerships | Specialty Retail | Neutral | New York Stock Exchange | Automotive Retail, Cost control, digital platform, e-commerce, Online Used Cars, profitability, Unit growth, Vehicle Refurbishment | Login |
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | AXON | Axon Enterprise | Aerospace & Defense | Aerospace & Defense | Bull | NASDAQ | AI implementation, growth metrics, Law Enforcement Technology, Mission-Critical, Public safety, Software, technology integration, valuation compression | Login |
| Apr 15, 2026 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | RBLX | Roblox | Electronic Gaming & Multimedia | Interactive Media & Services | Bull | New York Stock Exchange | cash flow generation, Engaged Users, Gaming Hits, Online Gaming Platform, social media, User Behavior, Viral Games, Virtual Experiences | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | RCL | Royal Caribbean Group | Consumer Discretionary | Hotels, Resorts & Cruise Lines | Neutral | New York Stock Exchange | Competition, Cruises, guidance, Pricing, Travel | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | ROST | Ross Stores, Inc. | Consumer Discretionary | Apparel Retail | Bull | NASDAQ | Comps, Execution, Margins, Offprice, retail | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | VST | Vistra Corp. | Utilities | Independent Power Producers | Neutral | New York Stock Exchange | AI, Power, Ppas, Sentiment, utilities | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | NTRA | Natera, Inc. | Health Care | Diagnostics | Bull | NASDAQ | diagnostics, Genomics, growth, Margins, Oncology | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | MDB | MongoDB, Inc. | Information Technology | Application Software | Bull | NASDAQ | AI, cloud, Databases, growth, Software | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | VEEV | Veeva Systems Inc. | Health Care | Health Care Technology | Neutral | New York Stock Exchange | AI, Competition, lifesciences, platform, Software | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | RBLX | Roblox Corporation | Communication Services | Interactive Media & Services | Neutral | New York Stock Exchange | cashflow, Gaming, Margins, platform, Users | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | AXON | Axon Enterprise, Inc. | Industrials | Security & Alarm Services | Neutral | NASDAQ | AI, Bookings, Drones, growth, Lawenforcement | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | TER | Teradyne, Inc. | Information Technology | Semiconductor Equipment | Bull | NASDAQ | AI, CapEx, growth, Semi Conductors, Testing | Login |
| Jan 19, 2026 | Fund Letters | Eric Mintz | CRS | Carpenter Technology Corporation | Materials | Specialty Metals | Bull | New York Stock Exchange | Aerospace, MRO, Oem, Pricing, Specialty-Metals | Login |
| Oct 19, 2025 | Fund Letters | Eric Mintz | MPWR US | Monolithic Power Systems, Inc. | Information Technology | Semiconductors | Bull | NASDAQ | AI, Automation, growth, Margins, Power management, semiconductors, valuation | Login |
| Oct 19, 2025 | Fund Letters | Eric Mintz | WYNN US | Wynn Resorts, Ltd. | Consumer Discretionary | Casinos & Gaming | Bull | NASDAQ | diversification, EBITDA, Gaming, Macau, recovery, Travel, valuation | Login |
| Oct 19, 2025 | Fund Letters | Eric Mintz | ALNY US | Alnylam Pharmaceuticals, Inc. | Health Care | Biotechnology | Bull | NASDAQ | Biotech, growth, innovation, pipeline, Rnai, Ttr, valuation | Login |
| Oct 19, 2025 | Fund Letters | Eric Mintz | INSM US | Insmed Inc. | Health Care | Biotechnology | Bull | NASDAQ | Approvals, Biotech, growth, Lung disease, pipeline, R&D, valuation | Login |
| Oct 19, 2025 | Fund Letters | Eric Mintz | MDB US | MongoDB, Inc. | Information Technology | Application Software | Bull | NASDAQ | AI, architecture, cloud, Databases, growth, Margins, Software | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ALNY | Alnylam Pharmaceuticals | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, Commercial Stage, Equity, Gene Silencing, rare diseases, RNAi Therapeutics, TTR Amyloidosis | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | TTD | Trade Desk | Communication Services | Interactive Media & Services | Bull | NASDAQ | adtech, Connected tv, digital advertising, Equity, independent platform, programmatic advertising, Strong Margins | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | MPWR | Monolithic Power Systems | Information Technology | Semiconductors | Bull | NASDAQ | AI data centers, Diversified End Markets, Equity, infrastructure, Power management, semiconductors, technology hardware | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | MDB | MongoDB | Information Technology | Systems Software | Bull | NASDAQ | Cloud computing, Database Software, Digital transformation, Document Database, Enterprise software, Equity, SaaS | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | AXON | Axon Enterprise | Industrials | Aerospace & Defense | Bull | NASDAQ | AI solutions, Drones, Equity, innovation, Law Enforcement Technology, Security Technology, TASER | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | WYNN | Wynn Resorts | Consumer Discretionary | Casinos & Gaming | Bull | NASDAQ | Casino Operator, Equity, Gaming, international markets, Luxury Resorts, Macau Recovery, UAE Expansion | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | DXCM | Dexcom | Health Care | Health Care Equipment | Bear | NASDAQ | Cgm, Continuous Glucose Monitoring, diabetes care, Equity, Market Share Risk, Medical devices, Product Quality Issues | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | FICO | Fair Isaac | Information Technology | Application Software | Bull | NYSE | analytics software, credit scoring, Data Monetization, Equity, FICO Score, financial services, Regulatory Challenge | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | WING | Wingstop | Consumer Discretionary | Restaurants | Bear | NASDAQ | Chicken Wings, comparable-store sales, consumer pressure, Equity, Fast casual, Lower-Income Consumer, Restaurant Franchisor | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | INSM | Insmed | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, Bronchiectasis, Equity, First-to-Market, lung diseases, rare diseases, Regulatory Approval | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | AXON | Axon Enterprise, Inc. | Industrials | Aerospace & Defense | Bull | NASDAQ | Drones, Hardware, Public safety, SaaS, Security | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | RCL | Royal Caribbean Cruises Ltd. | Consumer Discretionary | Hotels, Resorts & Cruise Lines | Bull | NYSE | consumer, Leisure, Pricing, Tourism, Travel | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | NET | Cloudflare, Inc. | Information Technology | Systems Software | Bull | NYSE | cloud, Edge, infrastructure, Security, Software | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | VST | Vistra Corp. | Utilities | Independent Power Producers & Energy Traders | Bull | NYSE | Contracts, data centers, Generation, Power, utilities | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | BKR | Baker Hughes Company | Energy | Oil & Gas Equipment & Services | Bull | NASDAQ | energy, Equipment, infrastructure, LNG, services | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | SRPT | Sarepta Therapeutics, Inc. | Health Care | Biotechnology | Bear | NASDAQ | Biotech, gene therapy, Neuromuscular, Regulation, Risk | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | OKTA | Okta, Inc. | Information Technology | Application Software | Bull | NASDAQ | cybersecurity, enterprise, Governance, Identity, Software | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | RYAN | Ryan Specialty Holdings, Inc. | Financials | Insurance | Bull | NYSE | Brokerage, E&s, Insurance, Margins, specialty | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | RH | RH | Consumer Discretionary | Specialty Stores | Bear | NYSE | consumer, Housing, Luxury, Macro, retail | Login |
| Jul 27, 2025 | Fund Letters | Eric Mintz | PLTR | Palantir Technologies, Inc. | Information Technology | Application Software | Bull | NYSE | AI, analytics, Defense, Government, Software | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | MPWR | Monolithic Power Systems | Information Technology | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | AI data centers, Diversified End Markets, Power management, semiconductors, technology hardware | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ASIC|CWAN|INSP|KRMN|KTOS|MAC|MEG|RH|WYNN | Wynn Resorts | Consumer Discretionary | Casinos & Gaming | Bull | NASDAQ | Casinos, Gaming, international markets, Luxury Resorts, Macau Recovery, UAE Expansion | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | MPWR | Monolithic Power Systems | Information Technology | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | AI data centers, Diversified End Markets, growth, Power management, semiconductors, technology | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ALNY | Alnylam Pharmaceuticals | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, Commercial Launch, Gene Silencing, RNAi Therapeutics, TTR Amyloidosis, Unmet Medical Needs | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ASIC|CWAN|INSP|KRMN|KTOS|MAC|MEG|RH|WYNN | Wynn Resorts | Consumer Discretionary | Casinos & Gaming | Bull | NASDAQ | Casinos, Gaming, international markets, Luxury Resorts, Macau, recovery, uae | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | INSM | Insmed | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, Bronchiectasis, First-to-Market, lung diseases, rare diseases, Unmet Medical Needs | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ALNY | Alnylam Pharmaceuticals | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, Commercial Launch, Gene Silencing, Guidance Raise, rare disease, Rnai, TTR Amyloidosis | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | MDB | MongoDB | Information Technology | Software | Bull | NASDAQ | Cloud computing, Database Software, Digital transformation, Document Database, Enterprise software, SaaS | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | INSM | Insmed | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, Bronchiectasis, First Therapy, lung diseases, rare disease, Regulatory Approval, Unmet Medical Need | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ARIS|BAB LN|GDDY|GXI|III LN|IOT|IRTC|MIPS SS|RBC|SAIA|SPOT|SRT GR|TTD|WING | The Trade Desk | Communication Services | Interactive Media & Services | Bull | NASDAQ | adtech, Connected tv, digital advertising, independent platform, programmatic advertising, Strong Margins | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | MDB | MongoDB | Information Technology | Software | Bull | NASDAQ | Application Development, Database Software, Digital transformation, Document-Oriented, enterprise, Modern Database, Software | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | AXON | Axon Enterprise | Industrials | Aerospace & Defense | Bull | NASDAQ | AI solutions, Body Cameras, Digital Evidence, Drones, Law Enforcement Technology, security solutions | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ARIS|BAB LN|GDDY|GXI|III LN|IOT|IRTC|MIPS SS|RBC|SAIA|SPOT|SRT GR|TTD|WING | The Trade Desk | Communication Services | Interactive Media & Services | Bull | NASDAQ | attractive valuation, competitive moat, Connected tv, digital advertising, independent platform, Programmatic, Strong Margins | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ARIS|BAB LN|GDDY|GXI|III LN|IOT|IRTC|MIPS SS|RBC|SAIA|SPOT|SRT GR|TTD|WING | Wingstop | Consumer Discretionary | Restaurants | Bear | NASDAQ | Chicken Wings, comparable-store sales, Fast casual, franchise model, Lower-Income Consumer, Restaurants | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | FICO | Fair Isaac | Information Technology | Software | Bull | NYSE | analytics software, credit scoring, Data Monetization, financial services, Regulatory Challenge, stock buyback | Login |
| Sep 30, 2025 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | DXCM | DexCom | Health Care | Health Care Equipment & Supplies | Bear | NASDAQ | Continuous Glucose Monitoring, diabetes care, Healthcare Technology, Market Share Loss, Medical devices, Product Quality Issues | Login |
| Dec 31, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | APP | AppLovin Corporation | Communication Services | Interactive Media & Services | Bull | NASDAQ | Analytics Platform, digital advertising, e-commerce, growth, Mobile App Development, SaaS, user acquisition | Login |
| Dec 31, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | MRVL | Marvell Technology Inc | Information Technology | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | Artificial Intelligence, cloud infrastructure, data centers, design wins, hyperscale, semiconductors, technology | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | GEV | GE Vernova | Industrials | Electrical Equipment | Bull | NYSE | electrical equipment, energy transition, Gas turbines, Industrial Equipment, infrastructure, Power generation, spin-off, utilities | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | CRWD | CrowdStrike | Information Technology | Systems Software | Bull | NASDAQ | Cloud computing, cybersecurity, endpoint protection, Enterprise security, Security Software, Software, Systems Software, technology leadership | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | VST | Vistra | Utilities | Independent Power and Renewable Electricity Producers | Bull | NYSE | Artificial Intelligence, data centers, electricity demand, Independent Power Producer, Power generation, Power Purchase Agreements, Technology Companies, utilities | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | WAB | Wabtec | Industrials | Industrial Machinery | Bull | NYSE | Digital Solutions, Freight Rail, Industrial Equipment, Locomotives, Modernization, rail industry, Transit Systems, Transportation | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | DXCM | Dexcom | Health Care | Health Care Equipment & Supplies | Bear | NASDAQ | Channel Strategy, Continuous Glucose Monitoring, Diabetes, Healthcare Technology, market share, Medical devices, Regulatory Approval, Sales Force | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | CELH | Celsius | Consumer Staples | Soft Drinks | Bear | NASDAQ | beverage industry, consumer staples, convenience stores, Distribution, Energy drinks, Functional Beverages, inventory management, Retail Traffic | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | AXON | Axon Enterprise | Industrials | Aerospace & Defense | Bull | NASDAQ | Artificial Intelligence, Body Cameras, Drones, law enforcement, Public safety, Software, TASER, Technology Solutions | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | SNPS | Synopsys | Information Technology | Application Software | Bull | NASDAQ | AI chips, Application Software, chip design, electronic design automation, Semiconductor Software, semiconductors, Software Tools, technology | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | FICO | Fair Isaac Corp | Information Technology | Application Software | Bull | NYSE | credit scoring, Data Management, Decision Analytics, financial services, Interest rates, Mortgage Activity, Predictive analytics, Software | Login |
| Sep 30, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | ENTG | Entegris | Information Technology | Electronic Equipment, Instruments & Components | Bull | NASDAQ | advanced materials, Chip Manufacturing, Consumables, Contamination Control, Microelectronics, semiconductor materials, specialty chemicals, Technology Components | Login |
| Dec 31, 2024 | Fund Letters | Carillon Eagle Mid Cap Growth Fund | AXON | Axon Enterprise Inc | Industrials | Aerospace & Defense | Bull | NASDAQ | Artificial Intelligence, Body Cameras, defense technology, Drones, Evidence Management, Law Enforcement Technology, TASER | Login |
| TICKER | COMMENTARY |
|---|---|
| VRT | Vertiv Holdings, a global leader in critical infrastructure for data centers and communication networks, delivered a quarter that significantly exceeded even the most bullish expectations. Strength was particularly evident in orders and backlog, providing strong visibility into future growth. The company is well positioned to benefit from accelerating data center investment, driven by rapid expansion in high-performance computing and artificial intelligence (AI). Vertiv's leadership in power and thermal management, combined with strategic relationships across leading semiconductor manufacturers and hyperscale customers, reinforces its role as a key enabler of next-generation AI infrastructure. |
| TER | Teradyne designs and manufactures testing equipment for semiconductors. Investors have appreciated its strong position in testing for next-generation memory and application-specific integrated circuit (ASIC) testing for AI workloads. Additionally, there is potential for the company to gain market share with the largest semiconductor company in the world. |
| CASY | Casey's General Stores operates a chain of convenience stores that sell fuel, groceries, and freshly prepared food, such as pizza, primarily in small-town and rural areas across the Midwest. The stock performed well, driven by strong quarterly results, with continued strength in fuel margins and robust in-store sales, particularly in prepared foods and pizza. It also benefitted from expectations that recent increases in oil prices could further expand fuel margins. |
| PWR | Quanta Services, a leading provider of infrastructure solutions across electric utility, energy, and data center markets in North America, delivered another strong quarter supported by solid execution. Results were complemented by continued backlog growth and constructive management commentary, reinforcing a robust outlook for future expansion. As a full-scale solutions provider with exposure spanning the AI infrastructure value chain, Quanta is distinctly positioned to capitalize on this generational investment cycle, which is driven by accelerating demand for power, connectivity, and data center capacity. |
| XPO | XPO, a leading provider of less-than-truckload (LTL) freight transportation services, delivered strong performance despite a challenging freight environment that has persisted for several years. The company's execution has been particularly evident in improving service levels, helping to narrow the market share and pricing gap with its best-in-class peer. Additionally, a recovery in the Institute for Supply Management® manufacturing Purchasing Managers' Index® (PMI®) above the key 50 threshold, along with constructive forward commentary from management, supported improved sentiment and contributed to the stock's strong performance during the quarter. |
| ARES | Ares Management is an alternative asset manager focused on private credit, private equity, real estate, and infrastructure investing. The stock was under pressure throughout the quarter as retail investors moved quickly to redeem private credit products, putting Ares' asset-raising capability and fund performance in question. Ares focuses more toward institutional products, and as this shakeout continues, we believe its business mix, diversification, and track record should help separate the company from peers. |
| CVNA | Carvana is an online used car retailer that enables customers to buy, sell, and finance vehicles through a fully digital platform. The stock sold off on quarterly results. While new units and revenue were strong, profitability trailed expectations. Costs associated with refurbishing vehicles rose more than expected. This cost issue is likely to take at least a quarter to regain control and in the near term takes the luster away from very strong unit growth. |
| AXON | Axon Enterprise, a market leader in next-generation law enforcement technology, delivered a strong quarterly update that drove upward revisions to key growth metric expectations. Despite this positive fundamental performance, the stock lagged as the market severely compressed valuation multiples across software and related industries, particularly those perceived as vulnerable to rapid advancements in artificial intelligence. In Axon's case, we believe this reaction is misplaced, as the company remains well positioned and has already demonstrated the ability to become a key adopter and implementer of AI, enhancing its product offerings while remaining mission-critical to customers' daily operations. |
| RBLX | Roblox provides an online gaming platform for children, teens and, increasingly, adults. After a very strong 2025 when some new games became major viral hits, investors have become concerned about the lack of similar enthusiasm for new games. Furthermore, the growing concern globally around the use of social media and games aimed at younger audiences has also weighed on sentiment, although we have not seen any changes in user behavior thus far. We remain positive on the company given its massive base of engaged users, cash flow generation, and the potential for new gaming hits to reaccelerate growth. |
| RDDT | Reddit is an online community platform where users share, discuss, and engage with content across a wide range of topics. The company posted solid revenue growth and profitability, while the closely watched metric of logged-in user growth was somewhat disappointing. Additional uncertainty around upcoming large language model (LLM) data-licensing renewals also pressured sentiment. The company authorized a stock buyback and provides an appealing audience for advertisers, as roughly half of its users are not active on other social media platforms. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||